Potential vaccine pops: nvax, ocugen
Ocugen had a big pop today on stupid news. I've been taking profits but this has attracted attention on wsb so could unsubstantially increase. Their market cap is tiny. Ocugen is way late to the game. They could have success in India and third world sales but overall the market will likely be saturated by other companies by the time ocugen succeeds. I also think their efficacy is inferior to other covid vaccines yet still acceptable and definitely better than the JJ vaccine. The news today was stupid so without data released, this will drop again, guessing around $10/share which is where it settled last. Positive news obviously will cause a dramatic spike.
So I'm still not a fan of nvax stock at these prices but it had a SIGNIFICANT over correction today because of EU supply news that has yet to be confirmed by the EU or Novavax-probably true tho. Honestly kind of annoying cuz I was expecting a big pop soon; they're due for EUA approval in Europe and elsewhere very soon and should be submitting EUA application in the US any day now. Just released news today on expansion to peds vaccine trials as well. The stock could very well likely be dropping for institutional investors to pile in for upcoming gains. It's very manipulated. It's annoying though because if these losses aren't recovered by news, the gains won't be as nice.
Disclaimer: I've been holding nvax since 2016 however I've sold more than enough to cover my cost and will be holding the rest long term cuz I like nanoflu. Therefore the short term swings aren't too important, but it's nice to see.
Another one that might be interesting to look into that I haven't checked out their financials is Retractable Technologies(RVP) . They make the VanishPoint syringe/needle system that is being used with a majority of covid vaccines since it's being shipped with the actual vaccine itself and also minimizes waste due to low dead space in the needle hub. Supply chains for needles and syringes is in disarray right now so as long as shortages persist they should be able to sell their products as fast as they can produce them. Expect vaccine programs to persist at the same pace for at least another 6-12months. We likely will need a booster. Next fall pediatrics 6 months and above will likely be receiving the covid vaccines so the demand will still be high.